Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Bata India shares slip following Citi's Sell rating

EditorAmbhini Aishwarya
Published 09/13/2023, 06:48 AM
Updated 09/13/2023, 06:48 AM
© Reuters.

Shares of Bata India, a leading footwear manufacturer, declined over 3% in the opening deals on Wednesday, after Citi initiated a Sell rating on the stock with a target price of Rs 1,310. This move follows Bata's subdued performance in Q1FY2024 and concerns about the company losing market share.

In the April-to-June quarter, Bata's gross margins decreased by 185 basis points year-on-year (YoY) to 54.8%. The EBITDA margin also saw a decline of 92 basis points YoY to 25.5%. Demand for mass products, which are priced under Rs 1,000 ($1 = INR82.973), remained weak during this period, despite growth in the company's premium portfolio.

Bata India’s sneaker portfolio grew by 1.15 times on a YoY basis, while Floatz, another brand towards the premium side, saw a growth of 2.06 times on a YoY basis. However, despite these developments and reach expansion initiatives, Bata's revenue compound annual growth rate (CAGR) over FY19-23 was only 4% - the lowest among the top-four listed footwear players in India.

Citi highlighted that Bata India has lost market share and has had a zero percent volume CAGR over the past decade. In comparison, Metro Brands’ revenue has grown at a CAGR of 15% over FY19-23, while Relaxo Footwears' revenue has grown at a CAGR of 7%in the same period.

By Wednesday afternoon, Bata India shares were down 1.11% at Rs 1681.95 on the National Stock Exchange (NSE). At the time of filing this report, the stock was trading 2.26% lower at Rs 1,662.60 on the Bombay Stock Exchange (BSE).

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The brokerage further added that the reverse discounted cash flow (DCF) at the current market price (CMP) of Rs 1701.05 on the BSE implies a 17.2% revenue CAGR over FY26–36E. This is against a 10.8% revenue CAGR pre-COVID in the past decade.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.